Countries China
Shanghai MicuRx Completes Phase III Trial of MRX-4, Advances Toward NDA Submission in China
Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx", 688373.SH) announced the successful completion of its Phase III clinical trial of MRX-4 for inject...
December 02, 2024 | News
Minghui Pharmaceutical Announces Positive Phase III Results for MH004 Ointment in Treating Atopic Dermatitis
Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, today announced...
December 02, 2024 | News
China’s 2024 National Reimbursement Drug List Expands Access to Cutting-Edge Therapies
The National Healthcare Security Administration of China has unveiled the 2024 National Reimbursement Drug List (NRDL), incorporating several pioneering th...
November 29, 2024 | News
Telix and Grand Pharma Dose First Patient in Phase III ZIRCON-CP Trial for ccRCC Imaging in China
Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) and Grand Pharmaceutical Group Limited (00512.HK, Grand Pharma) announce th...
November 29, 2024 | News
Allink Biotherapeutics Secures $42 Million Series A Funding to Drive Global Expansion of Next-Gen ADC and Bispecific Antibody Therapies
Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutic...
November 29, 2024 | News
Kelun-Biotech Secures China’s First Approval for TROP2-Directed ADC Sacituzumab Tirumotecan for Advanced Triple-Negative Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization in China from ...
November 28, 2024 | News
Merck and Abbisko Report Phase III Success for Pimicotinib in TGCT Treatment
Phase III MANEUVER study met primary endpoint, with an objective response rate at week 25 of 54.0% for pimicotinib versus 3.2% for placebo (p<0.0001) ...
November 27, 2024 | News
VectorBuilder and Sartorius Announce Strategic Partnership to Advance Gene Delivery and mRNA Bioprocess Solutions
VectorBuilder, a global leader in end-to-end gene delivery services, and Sartorius, a leading international partner in life science research and the biopha...
November 27, 2024 | News
Duality Biologics and Adcendo Expand Collaboration to Strengthen ADC Cancer Therapy Pipeline
Duality Biologics ("Duality"), a clinical-stage biotech company focusing on the discovery and development of next generation antibody-drug conjugate therap...
November 26, 2024 | News
ArkBio Completes Phase 1 Enrollment for AK0610, Pioneering RSV Prevention for Vulnerable Infants
Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") announced the successful enrollment and dosing of all participants in a Phase 1 clinical study of AK061...
November 25, 2024 | News
Lepu Biopharma and DP Technology Achieve Milestone in ADC Drug Development Through AI-Powered Collaboration
This partnership has effectively integrated DP's ADC Linker-Payload design platform with Lepu's ADC technology development platform, capitalizing on t...
November 22, 2024 | News
Ractigen Therapeutics Receives FDA Orphan Drug Designation for RAG-21, a Novel siRNA Therapy for FUS-ALS
Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated to developing innovative therapies, announced that the U.S. Food and Drug Administ...
November 20, 2024 | News
Huahui Health's Libevitug Receives FDA Breakthrough Therapy Designation for Chronic Hepatitis Delta
Huahui Health, a clinical-stage biotechnology company focused on discovering and developing novel therapies in the areas of viral hepatitis, hepatology, an...
November 19, 2024 | News
VelaVigo and Avenzo Therapeutics Join Forces to Develop Nectin4/TROP2 Bispecific ADC for Global Markets
VelaVigo Cayman Limited (VelaVigo), a biotech company focusing on discovery and development of multi-specific antibodies and antibody-drug conjugates...
November 19, 2024 | News
Most Read
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
